Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106788952 | 10678895 | 2 | F | 20160610 | 20141229 | 20160708 | PER | US-PFIZER INC-2014356447 | PFIZER | 65.00 | YR | F | Y | 0.00000 | 20160708 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106788952 | 10678895 | 1 | PS | CELEBREX | CELECOXIB | 1 | Oral | 200 MG, DAILY | U | 20998 | 200 | MG | CAPSULE, HARD | ||||||
| 106788952 | 10678895 | 2 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 40 MG, 1X/DAY | U | 20702 | 40 | MG | FILM-COATED TABLET | QD | |||||
| 106788952 | 10678895 | 3 | SS | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Nasal | 18 ?G, 1X/DAY | U | 0 | 18 | UG | INHALATION POWDER | QD | |||||
| 106788952 | 10678895 | 4 | C | ACETAMINOPHENHYDROCODONE BITARTRATE | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | Oral | UNK MG, AS NEEDED (HYDROCODONE BITARTRATE 10MG, PARACETAMOL 325MG) | 0 | ||||||||||
| 106788952 | 10678895 | 5 | C | ACETAMINOPHENHYDROCODONE BITARTRATE | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | Oral | 1 DF, AS NEEDED (6 HOURS AS NEEDED PAIN/HYDROCODONE: 10MG, PARACETAMOL: 325MG) | 0 | 1 | DF | ||||||||
| 106788952 | 10678895 | 6 | C | SINEX | 2 | Nasal | UNK, 2X/DAY (1 SPRAY BOTH NOSTRILS TWICE PER DAY) | 0 | 2 | DF | BID | ||||||||
| 106788952 | 10678895 | 7 | C | RANITIDINE HYDROCHLORIDE. | RANITIDINE HYDROCHLORIDE | 1 | Oral | 150 MG, 2X/DAY | 0 | 150 | MG | BID | |||||||
| 106788952 | 10678895 | 8 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 40 MG, AS NEEDED(2 PO Q DAY PRN) (2 BY MOUTH EVERY DAY AS NEEDED) | 0 | 40 | MG | ||||||||
| 106788952 | 10678895 | 9 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 10 MG, 1X/DAY | 0 | 10 | MG | QD | |||||||
| 106788952 | 10678895 | 10 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 20 MG, 1X/DAY (ONE BY MOUTH EVERY DAY) | 0 | 20 | MG | QD | |||||||
| 106788952 | 10678895 | 11 | C | VERAPAMIL HYDROCHLOIRDE | 2 | Oral | 80 MG, 2X/DAY | 0 | 80 | MG | TABLET | BID | |||||||
| 106788952 | 10678895 | 12 | C | VENTOLIN HFA | ALBUTEROL SULFATE | 1 | Oral | 2 PUFFS 108 (90 BA) AS NEEDED | 0 | 2 | DF | ||||||||
| 106788952 | 10678895 | 13 | C | ASPIRIN (E.C.) | ASPIRIN | 1 | Oral | 325 MG, 1X/DAY | 0 | 325 | MG | QD | |||||||
| 106788952 | 10678895 | 14 | C | FIORICET | ACETAMINOPHENBUTALBITALCAFFEINE | 1 | Oral | 1 EVERY 8 HOURS AS NEEDED | 50-325-40 | 0 | 1 | DF | TID | ||||||
| 106788952 | 10678895 | 15 | C | GABAPENTIN. | GABAPENTIN | 1 | Oral | 600 MG (2 X 300) THRICE DAILY | 0 | 600 | MG | TID | |||||||
| 106788952 | 10678895 | 16 | C | VITAMIN B COMPLEX | CYANOCOBALAMINDEXPANTHENOLNIACINAMIDEPYRIDOXINE HYDROCHLORIDERIBOFLAVIN 5'-PHOSPHATE SODIUMTHIAMINE HYDROCHLORIDEVITAMIN B COMPLEX | 1 | Oral | 1 DF, 1X/DAY | 0 | 1 | DF | QD | |||||||
| 106788952 | 10678895 | 17 | C | LORAZEPAM. | LORAZEPAM | 1 | Oral | 1 MG X 1 OR 2 EVERY NIGHT AT BEDTIME AS NEEDED | 0 | ||||||||||
| 106788952 | 10678895 | 18 | C | CITALOPRAM HYDROBROMIDE. | CITALOPRAM HYDROBROMIDE | 1 | Oral | 40 MG, 1X/DAY (ONE TABLET BY MOUTH EVERY DAY) | 0 | 40 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 106788952 | 10678895 | 4 | Pain |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 106788952 | 10678895 | Pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |